DOCSLIB.ORG

Legal-Graphics' 6-18-21 COVID Timeline

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Number of days since first sign of virus Overview: Year 2 of COVID Year 2 Nov. 23, 2020 Dec. 3, 2020 Dec. 11, 2020 Dec. 21, 2020 Dec. 30, 2020 Jan. 7, 2021 Jan.Jan. 14,7, 2021 2021 of COVID-19 Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths over 1,400,000 over 1,500,000 over 1,600,000 over 1,700,000 over 1,800,000 over 1,900,000 over 1,900,0002,000,000 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 Link to Nov. 16, 2020 Nov. 18, 2020 Nov. 21, 2020 Nov. 25, 2020 Nov. 27, 2020 Nov. 30, 2020 Dec. 3, 2020 Dec. 6, 2020 Dec. 8, 2020 Dec. 11, 2020 Dec. 14, 2020 Dec. 17, 2020 Dec. 21, 2020 Dec. 22, 2020 Dec. 26, 2020 Dec. 29, 2020 Dec. 31, 2020 Jan. 3, 2021 Jan. 5, 2021 Jan. 8, 2021 Jan. 11, 2021 Jan. 13, 2021 Jan. 17, 2021 Source Moderna says data FDA allows US cases top Picture of US Demand for live Moderna to request Map showing US UK gears up for Chart of cumulative Pfizer vaccine to be How do the Pfizer Vaccinations reach How the Pfizer Vaccines across Could AZD7442 Map showing How vaccinations Interactive US Map It’s lockdown No. 3 Pfizer vaccine Japan has found Initial Israeli data: Vaccine skepticism shows its vaccine 1st rapid virus test 12 million ... spread economy is Christmas trees emergency states with the huge vaccination number of deaths OK’d in days - and Moderna US nursing homes and Moderna the world prevent COVID-19 which countries were developed by county showing for England, at least appears effective a new Covid variant First Pfizer shot hurts East European Signs of Virus is more than that gives results 'faster' and 'broader' worrisome skyrockets amid authorization their highest number plan watched by country (by “normal” next fall vaccines work? vaccines compare infection have rolled out so quickly risk for COVID six weeks at home against mutation in curbs infections by anti-virus efforts at home as virus toll of virus number of days a COVID-19 vaccine new virus variants 50% after 14 days 94% effective than ever coronavirus vaccine of virus deaths by the world in those exposed? Jan. 11, 2021 Key Events inflicts damage since 100 deaths Dec. 18, 2020 Dec. 22, 2020 Dec. 31, 2020 Jan. 6, 2021 Jan. 17, 2021 Dec. 12, 2020 Dec. 15, 2020 Dec. 21, 2020 Jan. 4, 2021 US vaccine rollout US virus deaths Vaccines across Dec. 30, 2020 Jan. 9, 2021 Jan. 14, 2021 Dec. 1, 2020 Dec. 4, 2020 Dec. 7, 2020 Dec. 27, 2020 Where the world problematic Elderly hunger is Good News! Nov. 17, 2020 Nov. 19, 2020 Nov. 23, 2020 Nov. 28, 2020 Experts to consider and cases set Variant of virus 82 year old EU agency approves Dec. 9, 2020 Tracking nine of the US Nov. 26, 2020 The European Union records spreading across December is the Britain becomes 1st stands on dialysis patient Moderna vaccine US vaccine rollout STUDY: Recovering on the rise Governors ratchet > 900 Mayo Clinic AstraZeneca vaccine United Airlines Job growth China prepares the most promising approving Moderna Legal Matters eyes Dec 29, 2020 UK sending it deadliest month country to approve vaccination rollout gets first hits a snag from Covid gives during Covid up restrictions staff diagnosed (which only needs Macy’s is flying Pfizer slows sharply large-scale rollout US Hospitals under COVID-19 vaccines vaccine for US Jan. 11, 2021 approval for into “Tier Four” Dec. 23, 2020 in the US since the AstraZeneca vaccine AstraZeneca jab similar level of ahead of with COVID-19 to be refrigerated Thanksgiving Day COVID-19 vaccine as pandemic takes of coronavirus “extreme stress” Jan. 6, 2021 Dec. 19, 2020 lockdown coronavirus In US, Oklahoma’s protection to vaccine Oklahoma Events Thanksgiving - not frozen, like Parade marches on! 1st virus vaccine toll on economy vaccines and “overloaded” Jan. 1, 2021 Jan. 9, 2021 Jan. 18, 2021 Thailand grapples pandemic began Vaccine refusers scheduling portal Pfizer and Moderna) Dec. 13, 2020 Dec. 16, 2020 How many COVID-19 Dec. 30, 2020 Jan. 4, 2021 with virus outbreak may be limited Queen launches Israel trades Pfizer Economic News found to be 70-90% vaccines has each Demand for Jan. 15, 2021 Nov. 29, 2020 Dec. 2, 2020 Dec. 5, 2020 Canada secures Dec. 21, 2020 1st US case of virus Britain's jab blitz doses for effective Nov. 26, 2020 Dec. 10, 2020 Historic U.S. COVID country bought? rescue animals US vaccine Jan. 12, 2021 vaccine campaign early doses from Dec. 27, 2020 variant detected has skyrocketed administation Tracking US medical data Pandemic The 5 US states Moscow opens US Congress Dec. 23, 2020 Jan. 7, 2021 Hospitalizations launches with Moderna in Colorado tracker Irish infection rate COVID vaccine calls off Christmas with the most dozens of Sweden pulls a seals agreement “Hug booth” allows Jan. 10, 2021 in the US convoy of trucks US reports highest “world’s highest” distribution by state markets in Europe hospitalizations coronavirus U-turn and proposes on $900 billion US buys more doses nursing home hit another record Jan. 2, 2021 single-day death toll vaccination centers a lockdown law COVID relief bill of Pfizer vaccine residents to touch Johnson under fire as UK again faces Dec. 2, 2020 Dec. 13, 2020 their loved ones Jan. 12, 2021 Israel leads vaccine onslaught of Jan. 16, 2021 race with 12% Dec. 24, 2020 COVID-19 US reports its COVID-19 vaccine given jab Potential super China has suffered highest one-day in Oklahoma: spreader event a surge of cases death tally: Who gets it first? Santa Claus since December Overview: Over 2,800 is “good to go!” Year 1 of COVID Jan.Jan. 22,7, 2021 2021 Jan.Jan. 29,7, 2021 2021 Feb. 5, 2021 Feb. 13, 2021 Feb. 24, 2021 Mar. 7, 2021 Mar. 18, 2021 Mar. 29, 2021 Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths over 1,900,0002,100,000 over 1,900,0002,200,000 over 2,300,000 over 2,400,000 over 2,500,000 over 2,600,000 over 2,700,000 over 2,800,000 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 Jan. 19, 2021 Jan. 22, 2021 Jan. 25, 2021 Jan. 28, 2021 Jan. 31, 2021 Feb. 2, 2021 Feb. 5, 2021 Feb. 7, 2021 Feb. 10, 2021 Feb. 13, 2021 Feb. 16, 2021 Feb. 17,19, 2021 Feb. 17,22, 2021 Feb. 17,25, 2021 Feb. 17,27, 2021 Feb.Mar. 17,2, 2021 2021 Feb.Mar. 17,5, 2021 2021 Feb.Mar. 17,8, 2021 2021 Feb.Mar. 17,11, 2021 Feb.Mar. 14,17, 2021 Feb.Mar. 16,17, 2021 Feb.Mar. 19,17, 2021 Feb.Mar. 22,17, 2021 Feb.Mar. 25,17, 2021 Feb.Mar. 28,17, 2021 A new COVID-19 Lucky few hit Bernie happy his How is the COVID-19 US hospitalizations Israel's vaccine Johnson &Johnson Richer countries The US needs more Should you mix and India’s dramatic fall How the US states US death toll Comparing the Diagram of the Chinese vaccines Countries making FDA issues EUA Israel’s cases drop AstraZeneca’s EU Flashcards for Uptick of infections AstraZeneca vaccine Scientists mull clues “VIPIT” syndrome challenge: Mutations vaccine jackpot memes may raise vaccination campaign and ICU numbers rollout linked to seeks vaccine stockpile vaccines; viral sequencing match COVID-19 of cases leaves rank for safety nears 500,000 Spanish Flu to many mutations sweep much of dubious claims over for T-cell test after lockdown exit vaccine woes the main vaccines in 15 US states safe and effective on virus’ origin associated with rise along with cases for rare extra doses money for charity going in your state? are dropping infection fall clearance with FDA Africa is being How is your vaccines? experts stumped during COVID the COVID pandemic the world Covid-19 cases in new trial data AztraZeneca vaccine left behind state doing? Feb.Mar. 16,17, 2021 Feb.Mar. 19,17, 2021 Feb. 17,22, 2021 Feb. 17,28, 2021 Feb.Mar. 17,9, 2021 2021 Feb.Mar. 17,11, 2021 Feb.Mar. 14,17, 2021 Feb.Mar. 26,17, 2021 Jan. 31, 2021 Feb. 2, 2021 Feb. 5, 2021 Feb. 14, 2021 Feb.Mar. 23,17, 2021 Jan. 20, 2021 Jan. 22, 2021 Jan. 25, 2021 Jan. 28, 2021 Feb. 16, 2021 Feb. 17,20, 2021 Feb. 17,25, 2021 Feb.Mar. 17,3, 2021 2021 Feb.Mar. 17,5, 2021 2021 Signs the pandemic Feb.Mar. 29,17, 2021 Feb. 7, 2021 South African UK Study: Novavax UK variant detected Thai PM gets Two emerging Feb.
Recommended publications
  • Emerging Leaders in Biosecurity Initiative

    Emerging Leaders in Biosecurity Initiative

    Emerging Leaders in Biosecurity Initiative Class of 2017 A competitive fellowship program created to identify, develop, and provide networking opportunities Yearbook for the next generation of leaders in biosecurity. Emerging Leaders in Biosecurity Initiative Contents Letter: 3 Thomas V. Inglesby, Director; Anita Cicero, Deputy Director, Johns Hopkins Center for Health Security Executive Steering Committee 5 Class of 2017 Fellows 9-35 ELBI 2017 Year in Review 36-37 ELBI Program Staff 41 ELBI Alumni 42 Cover and Inside Cover Photo Overlay: Swine Flu Strain Virus Particles. Col- orized transmission electron micrograph of negatively stained SW31 (swine strain) influenza virus particles. Credit: NIAID Emerging Leaders in Biosecurity Initiative The ELBI Fellowship program is made possible through financial support from the Open Philanthropy Project, under management by the Johns Hopkins Center for Health Security, and with the leadership of the ELBI Executive Steering Committee. For more information, please visit the ELBI website: http://www.centerforhealthsecurity.org/our-work/emergingbioleaders Center for Health Security “Modern conditions make the scenario of a global pandemic more likely. Humans are encroaching on animal environments, raising chances for pathogens to adapt from animals to people. An increasing share of the planet lives in megacities, heightening the likelihood of person-to-person transmission of pathogens. The movement of people and microbes around the globe is more efficient than ever. The recent outbreaks of SARS, MERS, and Ebola are only small glimpses of how quickly a deadly virus can spread.” Tom Inglesby and Benjamin Haas Foreign Affairs November 21, 2017 Middle East Respiratory Syndrome Coronavirus particle envelope proteins immunolabeled with Rabbit HCoV-EMC/2012 primary antibody and Goat an- 1 ti-Rabbit 10 nm gold particles.
  • SYRA MADAD, D.H.Sc, M.Sc., MCP

    SYRA MADAD, D.H.Sc, M.Sc., MCP

    SYRA MADAD, D.H.Sc, M.Sc., MCP Syra Madad, D.H.Sc., M.Sc., MCP is nationally recognized leader in public health and special pathogen preparedness and response. She is Senior Director, System-wide Special Pathogens Program at New York City Health + Hospitals, the nation’s largest municipal healthcare delivery system overseeing special pathogen preparedness and response efforts across 11 acute care hospitals in addition to post-acute/long-term care facilities and ambulatory care sites. She is Principal Investigator of NYC Health + Hospitals Center for Global Healthcare Preparedness to Special Pathogens. In addition, Dr. Madad is Core Faculty in the National Ebola Training and Education Center (NETEC), funded by the Centers for Disease Control and Prevention (CDC) and the Assistant Secretary for Preparedness and Response (ASPR) and Assistant Professor in the Graduate Biotechnology/Biodefense Program at the University of Maryland. She is an Alumni Fellow at Johns Hopkins Bloomberg School of Public Health, Center for Health Security’s Emerging Leaders in Biosecurity Program and the Federal Bureau of Investigation’s Behavioral Informatics & Technological Enterprise Studies Program. Dr. Madad earned her Doctoral degree in Health Science with a concentration in Global Health from Nova Southeastern University, graduating with Alpha Eta Health Science Honor Society status. She obtained her Master of Science degree in Biotechnology with a concentration in Biodefense and Biosecurity and Bachelor of Science degree in Psychology from the University of Maryland. Dr. Madad holds numerous professional certifications, licenses and training certificates including Master Continuity Practitioner Certification (FEMA), Advanced Emergency Planning Certification, All Hazard Response (CBRNE) Training for Laboratory Personnel, Biosafety Level III Training, and Identification of the Primary Select Agents of Bioterrorism Training.
  • Clinical Laboratory Preparedness and Response Guide

    Clinical Laboratory Preparedness and Response Guide

    TABLE OF CONTENTS Table of Contents ...................................................................................................................................................................................... 2 State Information ....................................................................................................................................................................................... 7 Introduction .............................................................................................................................................................................................. 10 Laboratory Response Network (LRN) .......................................................................................................................................... 15 Other Emergency Preparedness Response Information: .................................................................................................... 19 Radiological Threats ......................................................................................................................................................................... 21 Food Safety Threats .......................................................................................................................................................................... 25 BioWatch Program ............................................................................................................................................................................ 27 Bio Detection Systems
  • Legal-Graphics' 6-26-21 COVID Timeline

    Legal-Graphics' 6-26-21 COVID Timeline

    Number of days since first sign of virus Overview: Year 2 of COVID Year 2 Nov. 23, 2020 Dec. 3, 2020 Dec. 11, 2020 Dec. 21, 2020 Dec. 30, 2020 Jan. 7, 2021 Jan.Jan. 14,7, 2021 2021 of COVID-19 Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths over 1,400,000 over 1,500,000 over 1,600,000 over 1,700,000 over 1,800,000 over 1,900,000 over 1,900,0002,000,000 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 Link to Nov. 16, 2020 Nov. 18, 2020 Nov. 21, 2020 Nov. 25, 2020 Nov. 27, 2020 Nov. 30, 2020 Dec. 3, 2020 Dec. 6, 2020 Dec. 8, 2020 Dec. 11, 2020 Dec. 14, 2020 Dec. 17, 2020 Dec. 21, 2020 Dec. 22, 2020 Dec. 26, 2020 Dec. 29, 2020 Dec. 31, 2020 Jan. 3, 2021 Jan. 5, 2021 Jan. 8, 2021 Jan. 11, 2021 Jan. 13, 2021 Jan. 17, 2021 Source Moderna says data FDA allows US cases top Picture of US Demand for live Moderna to request Map showing US UK gears up for Chart of cumulative Pfizer vaccine to be How do the Pfizer Vaccinations reach How the Pfizer Vaccines across Could AZD7442 Map showing How vaccinations Interactive US Map It’s lockdown No.
  • (Public Pack)Minutes Document for London Assembly (Plenary), 04/02

    (Public Pack)Minutes Document for London Assembly (Plenary), 04/02

    MINUTES Meeting: London Assembly (Plenary) Date: Thursday 4 February 2021 Time: 10.00 am Place: Virtual Meeting Copies of the minutes may be found at: http://www.london.gov.uk/mayor-assembly/london- assembly/whole-assembly Present: Navin Shah AM (Chair) Susan Hall AM Tony Arbour AM (Deputy Chairman) David Kurten AM Jennette Arnold OBE AM Joanne McCartney AM Shaun Bailey AM Dr Alison Moore AM Siân Berry AM Steve O'Connell AM Andrew Boff AM Caroline Pidgeon MBE AM Léonie Cooper AM Keith Prince AM Unmesh Desai AM Murad Qureshi AM Tony Devenish AM Caroline Russell AM Len Duvall AM Dr Onkar Sahota AM Florence Eshalomi AM MP Peter Whittle AM Nicky Gavron AM City Hall, The Queen’s Walk, London SE1 2AA Enquiries: 020 7983 4100 minicom: 020 7983 4458 www.london.gov.uk v1 2015 Greater London Authority London Assembly (Plenary) Thursday 4 February 2021 1 Apologies for Absence and Chair's Announcements (Item 1) 1.1 The Chair explained that in accordance with Government regulations, the meeting was being held on a virtual basis, with Assembly Members participating remotely. 1.2 The Clerk read the roll-call of Assembly Members who were participating in the meeting. Apologies for absence were received on behalf of Gareth Bacon AM MP and Andrew Dismore AM. 1.3 On behalf the London Assembly the Chair expressed condolences to Captain Sir Tom Moore’s family following his death, noting the hope and happiness he had brought to many during the COVID-19 pandemic. 1.4 The Chair provided an update on recent Assembly activity, including: the London Assembly’s Plenary meeting questioning the Mayor on his draft 2021/22 budget; the COVID-19 and homeworking event held to explore the impact of working from home mental and physical wellbeing; and the Fire, Resilience and Emergency Planning Committee’s meeting with the London Fire Commissioner, on the impacts of COVID-19 on the London Fire Brigade.
  • Framework for Equitable Allocation of COVID-19 Vaccine (2020)

    Framework for Equitable Allocation of COVID-19 Vaccine (2020)

    THE NATIONAL ACADEMIES PRESS This PDF is available at http://nap.edu/25917 SHARE Framework for Equitable Allocation of COVID-19 Vaccine (2020) DETAILS 260 pages | 6 x 9 | PAPERBACK ISBN 978-0-309-68224-4 | DOI 10.17226/25917 CONTRIBUTORS GET THIS BOOK Helene Gayle, William Foege, Lisa Brown, and Benjamin Kahn, Editors; Committee on Equitable Allocation of Vaccine for the Novel Coronavirus; Board on Health Sciences Policy; Board on Population Health and Public Health Practice; Health FIND RELATED TITLES and Medicine Division; National Academies of Sciences, Engineering, and Medicine; National Academy of Medicine SUGGESTED CITATION National Academies of Sciences, Engineering, and Medicine 2020. Framework for Equitable Allocation of COVID-19 Vaccine. Washington, DC: The National Academies Press. https://doi.org/10.17226/25917. Visit the National Academies Press at NAP.edu and login or register to get: – Access to free PDF downloads of thousands of scientific reports – 10% off the price of print titles – Email or social media notifications of new titles related to your interests – Special offers and discounts Distribution, posting, or copying of this PDF is strictly prohibited without written permission of the National Academies Press. (Request Permission) Unless otherwise indicated, all materials in this PDF are copyrighted by the National Academy of Sciences. Copyright © National Academy of Sciences. All rights reserved. Framework for Equitable Allocation of COVID-19 Vaccine Framework for Equitable Allocation of COVID-19 Vaccine Helene Gayle, William Foege, Lisa Brown, and Benjamin Kahn, Editors Committee on Equitable Allocation of Vaccine for the Novel Coronavirus Board on Health Sciences Policy Board on Population Health and Public Health Practice Health and Medicine Division PREPUBLICATION COPY: UNCORRECTED PROOFS Copyright National Academy of Sciences.
  • To Approve Pfizer-Biontech Vaccine: UK Regulator 2 December 2020

    To Approve Pfizer-Biontech Vaccine: UK Regulator 2 December 2020

    No 'corners cut' to approve Pfizer-BioNTech vaccine: UK regulator 2 December 2020 the jab began in June after interim results from early trials by US giant Pfizer and German newcomer BioNTech became available. "If you climb a mountain, you prepare and prepare," she added. "On 10th November we were at base camp. When we got the final analysis we were ready for that last sprint that takes us to today." British Health Secretary Matt Hancock said earlier the country's state-run National Health Service will start inoculations with 800,000 doses "early next week". Credit: Pixabay/CC0 Public Domain That will be ramped up to "millions" of jabs by the end of the year. Britain's independent medicines regulator said on The mass vaccination programme will begin with Wednesday no "corners have been cut" in its elderly care home residents and frontline health recommendation to approve Pfizer-BioNTech's and social care staff. COVID-19 vaccine for general use. © 2020 AFP The Medicines and Healthcare products Regulatory Agency (MHRA) said it had used overlapping trials and "rolling reviews" since June to reach the determination in record time. "That doesn't mean any corners have been cut—none at all," June Raine, its chief executive, said at a press conference. "The safety of the public will always come first." Wednesday's announcement saw Britain become the first Western country to approve a COVID-19 vaccine for general use, with jabs set to begin for the most vulnerable from next week. The Pfizer-BioNTech vaccine is one of several expected to gain regulatory approval in the coming weeks as similar reviews are completed.
  • SYRA MADAD, D.H.Sc, M.Sc., MCP

    SYRA MADAD, D.H.Sc, M.Sc., MCP

    SYRA MADAD, D.H.Sc, M.Sc., MCP Syra Madad, D.H.Sc., M.Sc., MCP is nationally recognized public health leader and epidemiologist in infectious disease and special pathogen preparedness and response. She is Senior Director, System-wide Special Pathogens Program at New York City Health + Hospitals, the nation’s largest municipal healthcare delivery system overseeing special pathogen preparedness and response efforts across 11 acute care hospitals in addition to post-acute/long-term care facilities and ambulatory care sites. She is Principal Investigator of NYC Health + Hospitals Institute of Diseases and Disaster Management and Health & Safety Lead of the Enhanced Special Investigations Unit of NYC Test & Trace Corp. In addition, Dr. Madad is Core Faculty in the National Emerging Special Pathogens Training and Education Center (NETEC), funded by the Centers for Disease Control and Prevention (CDC) and the Assistant Secretary for Preparedness and Response (ASPR). She is a Fellow at Harvard University’s Belfer Center for Science and Select Media Highlights on Dr. International Affairs, Adjunct Senior Fellow at the Federation of American Madad: • Fortune 40 Under 40 Scientists and part of their COVID19 Taskforce, Alumni Fellow at Johns • Netflix’s Pandemic: How to Prevent Hopkins Bloomberg School of Public Health, Center for Health Security’s an Outbreak Emerging Leaders in Biosecurity Program and Alumni Senior Fellow in the • Discovery The Vaccine: Conquering COVID Federal Bureau of Investigation’s Behavioral Informatics & Technological • Elemental 50 Experts to Trust in a Enterprise Studies Program. Pandemic • NY Magazine Feature on Dr. Syra Dr. Madad earned her Doctoral degree in Health Science with a Madad concentration in Global Health from Nova Southeastern University, • CNN: Disease Detectives graduating with Alpha Eta Health Science Honor Society status.
  • Frontline Hospital Planning Guide for Special Pathogens

    Frontline Hospital Planning Guide for Special Pathogens

    FRONTLINE HOSPITAL PLANNING GUIDE: SPECIAL PATHOGENS JUNE 2019 EMERGENCY MANAGEMENT Background: NYC Health + Hospitals is the largest municipal healthcare delivery system in the United States, providing essential inpatient, outpatient, and home-based services to more than one million New Yorkers every year in more than 70 locations across the city’s five boroughs. With our unique experiences in responding to emerging, re-emerging, and high consequence infectious disease incidents, including safely and successfully treating NYC’s single, confirmed case of Ebola virus disease and numerous persons under investigation, we understand first-hand the myriad impacts infectious disease threats and special pathogens events have on healthcare delivery. With the increasing demand for preparedness for and responses to the world’s emerging public health threats, this planning guide breaks new ground and leads the way as a distinctive domestic resource for healthcare delivery systems to customize their plans specific to their unique clinical, operational, and financial needs. Purpose and Audience: All hospitals must be prepared to identify and isolate a patient presenting with a suspected special pathogen infection (i.e., one that is particularly virulent and requires care processes and personal protective equipment beyond daily infection control practices) and inform internal and external stakeholders. This document provides high level planning guidance for a frontline hospital multidisciplinary team (e.g., emergency management, infection prevention and control, emergency department, inpatient care, safety, public relations, and infectious disease, depending on the resources and role of the facility in the community) to support planning and training for the provision of initial care to such patients while determining whether and when the patient will be transferred to another facility for further assessment and treatment.
  • Anna Frances Request-746058-E0cf701a

    Anna Frances Request-746058-E0cf701a

    Anna Frances MHRA [email protected] 10 South Colonnade Canary Wharf London E14 4PU United Kingdom www.gov.uk/mhra 7th May 2021 Dear Ms Frances, FOI 21/409 Thank you for your emails to MHRA customer services on 12th April 2021, where you asked questions relating to the COVID-19 vaccines, particularly inquiring on data on thromboembolic events and low platelets. In addition, you requested evidence of informed consent before people receive COVID-19 vaccines. Information on thromboembolic events and low platelets following a COVID-19 vaccine The MHRA has been proactively monitoring the safety of all approved COVID-19 vaccines for near real-time safety monitoring at the population level. A summary of Yellow Card reporting concerning the COVID-19 vaccines is published each week and can be found here. In this publication, you will find the specific information you have requested surrounding these case reports, including a breakdown of the age and sex of these patients and how many reports were fatal. The estimated number of first doses of COVID-19 Vaccine AstraZeneca administered in the UK by 28th April was 22.6 million and 5.9 million estimated second doses, giving an overall case incidence of 10.5 per million doses. Taking into account the different numbers of patients vaccinated with COVID-19 Vaccine AstraZeneca in different age groups, there is a higher reported incidence rate in the younger adult age groups compared to the older groups. MHRA advises that this evolving evidence should be taken into account when considering the use of the vaccine.
  • Local Community Partners to Provide Thanksgiving Groceries to Food

    Local Community Partners to Provide Thanksgiving Groceries to Food

    WEDNESDAY Fire Hazard Holiday Travel Fire weather to return to Millions stick to Southern California by Thanksgiving travel 11.25.20 holiday. plans despite warnings. Volume 20 Issue 11 Page 2 Page 5 @smdailypress @smdailypress Santa Monica Daily Press smdp.com Clara Harter GOLIATH: Cast and crew members with the popular television show “Goliath” stopped by the Ocean Lodge Hotel Tuesday to film scenes for the series’ upcoming season. “Goliath” follows Billy McBride, a formerly high-powered attorney who lives at the Ocean Lodge, as he rebuilds his legal career by taking on giant corporations and powerful billionaires. The char- acter, which is portrayed by Billy Bob Thornton, hangs out at the neighboring Chez Jay, a storied bar and restaurant that was built around the same time as the hotel and also happens to be where show creator David E. Kelley met his wife Michelle Pfeiffer. Local community partners to California officials issue provide Thanksgiving groceries to dire warnings about virus food-insecure families spread BY BRIAN MELLEY AND Barbara Ferrer. “Inaction in the face More than a thousand families CHRISTOPHER WEBER of this devastating acceleration of from the local community left Santa Associated Press cases will cause irreparable harm.” Monica College Tuesday with holiday Ferrer told supervisors that a meals consisting of fresh turkey, Los Angeles County supervisors proposed stay-home order would pumpkin pie and more as a result of voted Tuesday against allowing be more modest than a statewide the inaugural Giving Thanks(giving) restaurants to remain open for closure in the spring but was drive-thru event.
  • Legal-Graphics' 5-17-21 COVID Timeline

    Legal-Graphics' 5-17-21 COVID Timeline

    Number of days since Overview: Year 2 of COVID first sign of virus Year 2 Nov. 23, 2020 Dec. 3, 2020 Dec. 11, 2020 Dec. 21, 2020 Dec. 30, 2020 Jan. 7, 2021 Jan.Jan. 14,7, 2021 2021 of COVID-19 Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths over 1,400,000 over 1,500,000 over 1,600,000 over 1,700,000 over 1,800,000 over 1,900,000 over 1,900,0002,000,000 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 Link to Nov. 16, 2020 Nov. 18, 2020 Nov. 21, 2020 Nov. 25, 2020 Nov. 27, 2020 Nov. 30, 2020 Dec. 3, 2020 Dec. 6, 2020 Dec. 8, 2020 Dec. 11, 2020 Dec. 14, 2020 Dec. 17, 2020 Dec. 21, 2020 Dec. 22, 2020 Dec. 26, 2020 Dec. 29, 2020 Dec. 31, 2020 Jan. 3, 2021 Jan. 5, 2021 Jan. 8, 2021 Jan. 11, 2021 Jan. 13, 2021 Jan. 17, 2021 Source Moderna says data FDA allows US cases top Picture of US Demand for live Moderna to request Map showing US UK gears up for Chart of cumulative Pfizer vaccine to be How do the Pfizer Vaccinations reach How the Pfizer Vaccines across Could AZD7442 Map showing How vaccinations Interactive US Map It’s lockdown No.